Hidaka E, Yanagisawa A, Sakai Y, Seki M, Kitagawa T, Setoguchi T, Kato Y
Department of Pathology, Cancer Institute, Tokyo, Japan.
J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):439-43. doi: 10.1007/s004320050300.
This present study aimed to investigate the genetic changes in gallbladder carcinogenesis.
Eleven intramucosal gallbladder carcinomas were compared with 31 invasive lesions for loss of heterozygosity (LOH) on chromosomes 5q, 9p, 17p and 18q, frame-shift mutations in a ten-adenine repeat site within the gene encoding the transforming growth factor beta type II receptor (TGFbetaRII) and an eight-guanine repeat site within BAX, and point mutations in codon 12 of Ki-ras.
The incidences of LOH in intramucosal and invasive carcinomas were 14% and 17% on 5q, 9% and 52% on 9p, 64% and 65% on 17p, and 13% and 32% on 18q. No frame-shift mutations were found at TGFbetaRII or BAX, and point mutations in codon 12 of Ki-ras were present in only 8% of the samples. Thus, LOH on 17p was by far the most frequent lesion with similar results in both intramucosal and invasive carcinomas. In contrast, the frequency of LOH on 9p and 18q was distinctly higher in invasive lesions.
The present data suggest that LOH on 17p may play an important role in the evolution of gallbladder carcinoma from a relatively early phase, while LOH on 9p and 18q may play roles in progression.
本研究旨在调查胆囊癌发生过程中的基因变化。
将11例黏膜内胆囊癌与31例浸润性病变进行比较,检测5号染色体长臂(5q)、9号染色体短臂(9p)、17号染色体短臂(17p)和18号染色体长臂(18q)上的杂合性缺失(LOH),编码转化生长因子βⅡ型受体(TGFbetaRII)基因内一个十腺嘌呤重复位点和BAX基因内一个八鸟嘌呤重复位点的移码突变,以及Ki-ras基因第12密码子的点突变。
黏膜内癌和浸润性癌中5q上LOH的发生率分别为14%和17%,9p上分别为9%和52%,17p上分别为64%和65%,18q上分别为13%和32%。在TGFbetaRII或BAX中未发现移码突变,Ki-ras基因第12密码子的点突变仅在8%的样本中出现。因此,17p上的LOH是迄今为止最常见的病变,在黏膜内癌和浸润性癌中结果相似。相比之下,9p和18q上LOH的频率在浸润性病变中明显更高。
目前的数据表明,17p上的LOH可能在胆囊癌从相对早期阶段的演变中起重要作用,而9p和18q上的LOH可能在进展过程中起作用。